You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Benefits and Risks of early market access
- In: Breaking down barriers to patient access - How to bring stakeholders together on Wednesday, 5 September 2018, 14:30-17:30
- At: Glasgow (Scotland) (2018)
- Type: Presentation
- By: HUCKLE, Richard (Pope Woodhead & Associates Ltd, UK)
- Abstract:
Early access pathways are evolving, requiring multiple stakeholder interactions (including regulators, HTA bodies/payers and patients) with the aim to facilitate and accelerate development, marketing authorisation and access of medicines to patients in areas of high unmet needs.
Early access decisions are particularly challenging due to the
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026